Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Robin Chazot, Elisabeth Botelho-Nevers, Anne Frésard, Nicolas Maillard, Christophe Mariat, Frédéric Lucht & Amandine Gagneux-Brunon. (2017) Diagnostic challenges of kidney diseases in HIV-infected patients. Expert Review of Anti-infective Therapy 15:10, pages 903-915.
Read now
Read now
Articles from other publishers (23)
Jiapeng Li, Jian Shi, Jingcheng Xiao, Lana Tran, Xinwen Wang & Hao-Jie Zhu. (2022) Contributions of Cathepsin A and Carboxylesterase 1 to the Hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis. Drug Metabolism and Disposition 50:3, pages 243-248.
Crossref
Crossref
Sarah-Jane Anderson, Chiung-Yuan Hsu, Huang-Tz Ou, Nai-Ying Ko, Chun-Ting Yang & Sara Lopes. (2021) Cost-Effectiveness of Juluca for Human Immunodeficiency Virus Infection Treatment in Virologically Suppressed Adults in Taiwan. Value in Health Regional Issues 24, pages 216-223.
Crossref
Crossref
Lynda Stranix-Chibanda, Camlin Tierney, Dorothy Sebikari, Jim Aizire, Sufia Dadabhai, Admire Zanga, Cynthia Mukwasi-Kahari, Tichaona Vhembo, Avy Violari, Gerard Theron, Dhayandre Moodley, Kathleen George, Bo Fan, Markus J. Sommer, Renee Browning, Lynne M. Mofenson, John Shepherd, Bryan Nelson, Mary Glenn Fowler & George K. Siberry. (2021) Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial. PLOS ONE 16:2, pages e0246272.
Crossref
Crossref
Zhijie Xu, Pengyuan He, Jianzhong Xian, Wuzhu Lu, Jingxian Shu, Wentao Luo, Chongjie Gan, Ruoman Ke, Jinyu Xia, Zongping Han & Mingxing Huang. (2021) Association between Nonalcoholic Fatty Liver Disease and Bone Mineral Density in HIV-Infected Patients Receiving Long-term TDF-Based Antiretroviral Therapy. Current HIV Research 19:1, pages 40-46.
Crossref
Crossref
Denise L. Jacobson, Wendy Yu, Rohan Hazra, Sean Brummel, Mitchell E. Geffner, Kunjal Patel, William Borkowsky, Jiajia Wang, Janet S. Chen, Ayesha Mirza & Linda A. DiMeglio. (2020) Fractures in children and adolescents living with perinatally acquired HIV. Bone 139, pages 115515.
Crossref
Crossref
Regina B. Balter, Ludmila S. Tselkovich, Evgeniy Yu. Ryabov, Tatiana V. Ivanova, Alina R. Ibragimova & Olesya A. Ilchenko. (2020) The course of pregnancy and its outcome in HIV-infected women depending on the stage of the disease and the dosage regimen in antiretroviral therapy. Aspirantskiy Vestnik Povolzhiya 19:5-6, pages 6-12.
Crossref
Crossref
H‐J Stellbrink, A Lazzarin, I Woolley & JM Llibre. (2020) The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV. HIV Medicine 21:S1, pages 3-16.
Crossref
Crossref
Anna M Geretti. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
17
.
Takeshi NishijimaHiroyuki GatanagaShinichi Oka. (2019) Tenofovir nephrotoxicity among Asians living with HIV: review of the literature. Global Health & Medicine 1:2, pages 88-94.
Crossref
Crossref
Montserrat G. García, Unai Larrinaga-Torrontegui, Eduardo Eduardo Martinez, Unax Lertxundi, Itziar Palacios-Zabalza & Carmelo Aguirre. (2019) Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database. American Journal of Therapeutics 26:5, pages e589-e592.
Crossref
Crossref
Jean-Rodolphe Mackanga, Clémence Alène, Nancy Doumingou, Émeline-Gracia Mouendou Mouloungui, Alexandrine Nsie, Priscille Edou, Bellyse Lacmou, Patrick Nzouto, Greta Oliveira Bere, Franck-Éric Ehoumba Odzaga, Ulrich Davy Kombila, Patrice-Emery Itoudi Bignoumba, Landry Missounga, Josaphat Ibaba, Jean-Baptiste Moussavou Kombila & Jean-Bruno Boguikouma. (2019) The baseline glomerular filtration rate, predictive of six-year survival in sub-Saharan African patients on antiretroviral therapy for HIV: Cohort study. Néphrologie & Thérapeutique 15:4, pages 220-225.
Crossref
Crossref
E. Biver, A. Calmy, B. Aubry-Rozier, M. Birkhäuser, H. A. Bischoff-Ferrari, S. Ferrari, D. Frey, R. W. Kressig, O. Lamy, K. Lippuner, N. Suhm & C. Meier. (2019) Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis. Osteoporosis International 30:5, pages 1125-1135.
Crossref
Crossref
Jordi Navarro, José Ramón Santos, Ana Silva, Joaquin Burgos, Vicenç Falcó, Esteban Ribera, Arkaitz Imaz & Adrian Curran. (2019) Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:4, pages 501-507.
Crossref
Crossref
Willem Daniel Francois Venter, Andrew Kambugu, Matthew F. Chersich, Stephen Becker, Andrew Hill, Natasha Arulappan, Michelle Moorhouse, Mohammed Majam, Godspower Akpomiemie, Simiso Sokhela, Selvamuthu Poongulali, Charles Feldman, Chris Duncombe, David H. Brown Ripin, Alinda Vos & Nagalingeswaran Kumarasamy. (2019) Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 80:2, pages 224-233.
Crossref
Crossref
Ian McGowan, Timothy Wilkin, Raphael J. Landovitz, Chunyuan Wu, Ying Chen, Mark A. Marzinke, Craig W. Hendrix, Paul Richardson, Susan H. Eshleman, Adriana Andrade, Wairimu Chege, Peter L. Anderson, Marybeth McCauley, Jason Farley, Kenneth H. Mayer, Peter Anton, Rhonda M. Brand, Ross D. Cranston & Roy Gulick. (2019) The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM. AIDS 33:2, pages 237-246.
Crossref
Crossref
Maria Llop, W. A. Sifuentes, S. Bañón, C. Macia-Villa, M. J. Perez-Elías, M. Rosillo, S. Moreno, M. Vázquez & J. L. Casado. (2018) Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age. Archives of Osteoporosis 13:1.
Crossref
Crossref
Arnoo Shaiykova, Armelle Pasquet, Cécile Goujard, Georges Lion, Emmanuel Durand, Tatiana Bayan, Marie Lachâtre, Philippe Choisy, Faïza Ajana, Katia Bourdic, Nathalie Viget, Bertrand Riff, Yann Quertainmont, Bernard Cortet, Faroudy Boufassa & Antoine Chéret. (2018) Reduced bone mineral density among HIV-infected, virologically controlled young men. AIDS 32:18, pages 2689-2696.
Crossref
Crossref
G. Villa, R.O. Phillips, C. Smith, A.J. Stockdale, A. Beloukas, L.T. Appiah, D. Chadwick, A. Ruggiero, F.S. Sarfo, F. Post & AM Geretti. (2018) Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana. Journal of Infection 76:6, pages 515-521.
Crossref
Crossref
Joanne LaFleur, Adam P. Bress, Joel Myers, Lisa Rosenblatt, Jacob Crook, Kristin Knippenberg, Roger Bedimo, Pablo Tebas, Heather Nyman & Stephen Esker. (2018) Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals. Infectious Diseases and Therapy 7:2, pages 293-308.
Crossref
Crossref
Mariska C. Vlot, Marlous L. Grijsen, Jan M. Prins, Renate T. de Jongh, Robert de Jonge, Martin den Heijer & Annemieke C. Heijboer. (2018) Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection. PLOS ONE 13:3, pages e0193679.
Crossref
Crossref
Joanne LaFleur, Adam P. Bress, Stephen Esker, Kristin Knippenberg, Jacob Crook, Heather Nyman, Roger Bedimo, Pablo Tebas & Lisa Rosenblatt. (2018) Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals. JAIDS Journal of Acquired Immune Deficiency Syndromes 77:3, pages 325-330.
Crossref
Crossref
Willem Daniel Francois Venter, Nathan Ford, Marco Vitoria & Wendy Stevens. (2017) Diagnosis and monitoring of HIV programmes to support treatment initiation and follow up and improve programme quality. Current Opinion in HIV and AIDS 12:2, pages 117-122.
Crossref
Crossref
Sreekumar Othumpangat, Sidhartha D. Ray & John D. Noti. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
269
282
.